Literature DB >> 10859231

Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion.

B S Kaur1, R Ouatu-Lascar, M B Omary, G Triadafilopoulos.   

Abstract

Barrett's esophagus (BE) results from acid and bile reflux and predisposes to cancer. We investigated the effect of bile salts, with or without acid, on cell proliferation in BE and assessed mechanism(s) involved. To mimic physiological conditions, biopsies of esophagus, BE, and duodenum were exposed to a bile salt mixture, either continuously or as a 1-h pulse, and were compared with control media without bile salts (pH 7.4) for < or =24 h. Similar experiments were also performed with acidified media (pH 3.5) combined with the bile salt mixture as a 1-h pulse. Cell proliferation was assessed by a [(3)H]thymidine incorporation assay with or without bisindolylmaleimide (BIM), a selective protein kinase C inhibitor. Bile salt pulses enhanced cell proliferation in BE without affecting cell proliferation in esophageal or duodenal epithelia. In the presence of BIM, there was complete obliteration of the bile salt-induced BE hyperproliferation. In contrast, 1-h pulses of bile salts in combination with acid significantly inhibited proliferation in BE but had no effect on esophagus or duodenum. We conclude that in BE explants, brief exposure to bile salts, in the absence of acid, increases proliferation, whereas exposure to a combination of bile salts and acid together inhibits proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859231     DOI: 10.1152/ajpgi.2000.278.6.G1000

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  18 in total

1.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

2.  miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.

Authors:  Cameron M Smith; David I Watson; Mary P Leong; George C Mayne; Michael Z Michael; Bas P L Wijnhoven; Damian J Hussey
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

Review 3.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

4.  Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy.

Authors:  Giovanni Zaninotto; Paola Parente; Renato Salvador; Fabio Farinati; Chiara Tieppo; Nicola Passuello; Lisa Zanatta; Matteo Fassan; Francesco Cavallin; Mario Costantini; Claudia Mescoli; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona; Massimo Rugge
Journal:  J Gastrointest Surg       Date:  2011-11-16       Impact factor: 3.452

Review 5.  The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.

Authors:  David E Fleischer; Robert Odze; Bergein F Overholt; John Carroll; Kenneth J Chang; Ananya Das; John Goldblum; Daniel Miller; Charles J Lightdale; Jeffrey Peters; Richard Rothstein; Virender K Sharma; Daniel Smith; Victor Velanovich; Herbert Wolfsen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-20       Impact factor: 3.199

6.  Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

Authors:  R C Fitzgerald; S Abdalla; B A Onwuegbusi; P Sirieix; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...?

Authors:  Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

Review 8.  Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

9.  Induction of intestinalization in human esophageal keratinocytes is a multistep process.

Authors:  Jianping Kong; Hiroshi Nakagawa; Brandon K Isariyawongse; Shinsuke Funakoshi; Debra G Silberg; Anil K Rustgi; John P Lynch
Journal:  Carcinogenesis       Date:  2008-10-08       Impact factor: 4.944

Review 10.  Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long-term follow-up, review of the literature, and addition of six patients.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.